Press Information Bureau

#Unite2FightCorona#IndiaFightsCorona

PRESS INFORMATION BUREAU

MINISTRY OF INFORMATION & BROADCASTING

GOVERNMENT OF INDIA

COVID-19 Update

India’s Cumulative COVID-19 Vaccination Coverage crosses the landmark of 83 Cr

More than 71 Lakh doses administered in the last 24 hours

Recovery Rate currently at 97.77%

31,923 New Cases reported in the last 24 hours

India's Active Caseload (3,01,640) is 0.90% of Total Cases

Weekly Positivity Rate (2.11%) less than 3% for last 90 days

With the administration of 71,38,205 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage crossed the landmark of 83Cr (83,39,90,049) as per provisional reports till 7 am today. This has been achieved through 81,69,260sessions.

The break-up of the cumulative figureas per the provisional report till 7 am today include:

The recovery of 31,990 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,28,15,731.

Consequently, India’s recovery rate stands at 97.77%. Recovery Rate is currently at its highest peak since March 2020.

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 88 consecutive days now.

31,923 new cases were reported in the last 24 hours.

The Active Caseload is presently 3,01,640. Active cases presently constitute 0.90% of the country's total Positive Cases. This is the lowest figure in active cases in India since March 2020.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of

15,27,443tests being conducted. India has so far conducted over 55.83 Cr (55,83,67,013) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 2.11% remains less than 3% for the last 90 days now. The Daily Positivity rate reported to be2.09%. The daily Positivity rate has remained below3% for last 24 days and below 5% for 107 consecutive days now.

Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1757137

Update on COVID-19 Vaccine Availability in States/UTs

More than 80.67Crore vaccine doses provided to States/UTs

More than 4.29 Crore balance and unutilized vaccine doses still available with States/UTswith 64 Lakh doses in Pipeline

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccinemanufacturers in the country to States and UTs.

More than 80.67crore(80,67,26,335) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category.Further, 64Lakh doses (64,00,000) are in the pipeline.

More than 4.29Cr (4,29,03,090)balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.

Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1757136

Prime Minister’s comments at the Global COVID-19 Summit: Ending the Pandemic and Building Back Better Health Security to Prepare for the Next

Prime Minister’s comments at the Global COVID-19 Summit:

Excellencies,

The COVID-19 pandemic has been an unprecedented disruption. And, it is not yet over. Much of the world is still to be vaccinated.That is why this initiative by President Biden is timely and welcome.

Excellencies,

India has always seen humanity as one family. India's pharmaceutical industry has produced cost-effective diagnostic kits, drugs, medical devices, and PPE kits. These are providing affordable options to many developing countries. And, we have shared medicines and medical supplies with over 150 countries. Two indigenously developed vaccines have received "Emergency Use Authorization" in India, including the world's first DNA-based vaccine.

Several Indian companies are also involved in licensed production of various vaccines.

Earlier this year, we shared our vaccine production with 95 other countries, and with UN peace-keepers. And, like a family, the world also stood with India when we were going through a second wave.

For the solidarity and support extended to India, I thank you all.

Click here to read Prime Minister’s comments at the Global COVID-19 Summit:https://pib.gov.in/PressReleseDetail.aspx?PRID=1757110

Union Health Minister Shri Mansukh Mandaviya releases Post Covid Sequelae Modules

“These modules will provide guidance to doctors and health care workers to deal with the issue of long term effects of COVID”: Shri Mandaviya

“If the Frontline workers are equipped with proper knowledge and training, they can become a valuable resource in this fight against post-COVID challenges”: Dr Bharati Pravin Pawar

Union Minister for Health and Family Welfare Shri Mansukh Mandaviya released Post COVID Sequelae Modules in the presence of Dr. Bharati Pravin Pawar, Minister of State for Health and Family Welfare. These modules will help in building the capacity of the doctors, nurses, paramedics and community health workers across India to deal with long term effects of COVID.

Expressing his happiness on the release of guidelines, the Union Health Minister said that these have been prepared to provide guidance to doctors and health care workers to deal with the issue of long term effects of COVID. He said that proactive and comprehensive treatment of COVID is required to ensure minimum side effects and no negative effect of the treatment.

Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1757110

Important Tweets

*********

AS